IL164805A0 - Method for obtaining a2-18f-fluor-2-deoxy-d-glucose(18f-fdg)-solution - Google Patents

Method for obtaining a2-18f-fluor-2-deoxy-d-glucose(18f-fdg)-solution

Info

Publication number
IL164805A0
IL164805A0 IL16480503A IL16480503A IL164805A0 IL 164805 A0 IL164805 A0 IL 164805A0 IL 16480503 A IL16480503 A IL 16480503A IL 16480503 A IL16480503 A IL 16480503A IL 164805 A0 IL164805 A0 IL 164805A0
Authority
IL
Israel
Prior art keywords
fdg
fluor
deoxy
glucose
solution
Prior art date
Application number
IL16480503A
Other languages
English (en)
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of IL164805A0 publication Critical patent/IL164805A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16480503A 2002-04-24 2003-04-23 Method for obtaining a2-18f-fluor-2-deoxy-d-glucose(18f-fdg)-solution IL164805A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076638A EP1356827A1 (en) 2002-04-24 2002-04-24 Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
PCT/US2003/012603 WO2003090789A1 (en) 2002-04-24 2003-04-23 Method for obtaining a 2-18f-fluor-2-deoxy-d-glucose (18f-fdg) - solution

Publications (1)

Publication Number Publication Date
IL164805A0 true IL164805A0 (en) 2005-12-18

Family

ID=28685968

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16480503A IL164805A0 (en) 2002-04-24 2003-04-23 Method for obtaining a2-18f-fluor-2-deoxy-d-glucose(18f-fdg)-solution
IL164805A IL164805A (en) 2002-04-24 2004-10-25 Method for obtaining a stable solution of 2-F18-fluorine-2-deoxy-D-glucose (-FDG F18)

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL164805A IL164805A (en) 2002-04-24 2004-10-25 Method for obtaining a stable solution of 2-F18-fluorine-2-deoxy-D-glucose (-FDG F18)

Country Status (13)

Country Link
US (1) US8182788B2 (pl)
EP (2) EP1356827A1 (pl)
JP (2) JP5132869B2 (pl)
KR (1) KR20050005456A (pl)
CN (1) CN1323724C (pl)
AT (1) ATE422903T1 (pl)
AU (1) AU2003225124B2 (pl)
CA (1) CA2483181C (pl)
DE (1) DE60326220D1 (pl)
IL (2) IL164805A0 (pl)
NO (1) NO329160B1 (pl)
PL (1) PL371682A1 (pl)
WO (1) WO2003090789A1 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
CA2610252A1 (en) * 2005-06-14 2006-12-21 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
WO2007148083A2 (en) * 2006-06-21 2007-12-27 Ge Healthcare As Stabilisation of radiopharmaceutical precursors
WO2007148755A1 (ja) * 2006-06-21 2007-12-27 Nihon Medi-Physics Co., Ltd. 新規アミロイド親和性化合物
US20100056826A1 (en) * 2006-11-09 2010-03-04 Nihon Medi-Physicis Co., Ltd. Radioactive diagnostic imaging agent
US8790620B2 (en) * 2006-12-21 2014-07-29 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
TWI406674B (zh) 2007-02-13 2013-09-01 Nihon Mediphysics Co Ltd Method for manufacturing diagnostic radiographic diagnostic agents
CA2703649A1 (en) * 2007-10-24 2009-04-30 Shigeyuki Tanifuji Novel compound having affinity for amyloid
US20100267952A1 (en) * 2007-10-30 2010-10-21 Nihon Medi-Physics Co., Ltd. Use of novel compound having affinity for amyloid, and process for production of the same
US20100216994A1 (en) * 2007-10-30 2010-08-26 Nihon Medi-Physics Co., Ltd. Use of novel compound having affinity for amyloid, and process for production of the same
RU2474435C2 (ru) * 2007-11-07 2013-02-10 Джи-И Хелткер БВ Стабилизация радиофармацевтических композиций
KR101602992B1 (ko) 2009-04-15 2016-03-11 랜티우스 메디컬 이메징, 인크. 아스코르브산을 사용한 방사성 약제 조성물의 안정화
ES2785990T3 (es) * 2010-08-13 2020-10-08 Siemens Medical Solutions Usa Inc Formulación, aparato y método para estabilizar productos radiofarmacéuticos
KR20130132892A (ko) 2010-12-29 2013-12-05 지이 헬쓰케어 리미티드 용리제 용액
US20130004414A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
US20130005958A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
GB2509476B (en) * 2011-12-21 2018-08-08 Ge Healthcare Ltd Ip 18F - Fluciclovine compositions in citrate buffers
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
FR3054445B1 (fr) * 2016-07-26 2019-07-05 Laboratoires Cyclopharma Synthese d'une composition d'agent radioactif
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
GB202005282D0 (en) * 2020-04-09 2020-05-27 Blue Earth Diagnostics Ltd Pharmaceutical Formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
SE9002117L (sv) * 1990-06-14 1991-08-26 Nils Elander Mikrovaagsanordning foer behandling av precessvaetskor
DE69133514T2 (de) 1990-07-06 2006-09-28 Mallinckrodt, Inc. Verfahren zur herstellung einer lösung eines radioaktiven rhenium-komplexes
JPH0797340A (ja) * 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
BE1010280A3 (fr) 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.
IL129263A0 (en) * 1996-10-07 2000-02-17 Du Pont Merck Pharma Radiopharmaceuticals for imaging infection and inflammation

Also Published As

Publication number Publication date
NO20045070L (no) 2004-11-22
US20050175536A1 (en) 2005-08-11
CA2483181C (en) 2011-06-28
AU2003225124A1 (en) 2003-11-10
JP5132869B2 (ja) 2013-01-30
JP2006500319A (ja) 2006-01-05
IL164805A (en) 2009-06-15
WO2003090789A1 (en) 2003-11-06
CN1646175A (zh) 2005-07-27
EP1496946A1 (en) 2005-01-19
CN1323724C (zh) 2007-07-04
KR20050005456A (ko) 2005-01-13
PL371682A1 (pl) 2005-06-27
JP2010248244A (ja) 2010-11-04
US8182788B2 (en) 2012-05-22
EP1356827A1 (en) 2003-10-29
EP1496946B1 (en) 2009-02-18
ATE422903T1 (de) 2009-03-15
CA2483181A1 (en) 2003-11-06
AU2003225124B2 (en) 2007-06-14
NO329160B1 (no) 2010-08-30
DE60326220D1 (de) 2009-04-02

Similar Documents

Publication Publication Date Title
IL164805A0 (en) Method for obtaining a2-18f-fluor-2-deoxy-d-glucose(18f-fdg)-solution
WO2007014110A3 (en) Method and system for evaluating delivered dose
GB2411990B (en) Improved architecture for generating intermediate representations for program code conversion
WO2007010534A3 (en) Imaging protocols
EP3537217A3 (en) Positive resist composition, resin used for the positive resist composition, compound used for synthesis of the resin and pattern forming method using the positive resist composition
IL158650A0 (en) Polysiloxane, process for production thereof and radiation-sensitive resin composition
EP1829936A4 (en) ACTIALLY HARDENABLE COMPOSITION, ACTIALLY HARDENABLE INK AND IMAGING METHOD
ATE539698T1 (de) Zahnärztliches implantatsystem
WO2008133108A1 (ja) エポキシシリコーン及びその製造方法、並びに、それを用いた硬化性樹脂組成物とその用途
NO20054615L (no) Mikrobolgemetode
DE60028600D1 (de) Uv-härtbare zusammensetzungen
CA2585802A1 (en) Industrial process for the preparation of 17-hydroxy-6.beta.,7.beta.;15.beta.,16.beta.-bismethylene-3-oxo-17.alpha.pregn-4-ene-21-carboxylic acid.gamma.-lactone and key-intermediates for this process
DE502006000814D1 (de) Medizinisches, insbesondere dentalmedizinisches Handstück
AU2003294361A8 (en) Selectively locking device
ATE323095T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
WO2007017794A3 (en) Skin-treatment device
ES2103623T3 (es) Procedimiento de obtencion de zeolitas que contienen titanio.
UA86775C2 (ru) Способ очистки раствора альфа-1-антитрипсина
NL1025709A1 (nl) 3-(1-[3-(1,3-Benzothiazol-6-yI)propylcarbamoyl]cycloalkyI)propaanzuurderivaten Derivatives als NEP-remmers.
DE50306947D1 (de) Sequenzgestell
ITMI20022185A1 (it) Processo per la preparazione di fenolo mediante idrodeossigenazione di benzendioli.
ATE332902T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
EP1491951A3 (en) Positive-working resist composition
BR0005316A (pt) Processo e dispositivo para aproveitamento de compostos orgânicos nitrogenados, por gaseificação
GB2382393B (en) Fastening element